Latest Trials

EudraCT Number: 2004-001362-40

Sponsor Protocol Number: CSTI571BIT15

Start Date: 2004-07-22

Sponsor Name: NOVARTIS FARMA

Full Title: PHASE II STUDY OF IMATINIB MESYLATE IN CHORDOMA

Medical condition: Treatment of advanced or unresectable chordoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10008747		PT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

Sponsors and Collaborators